Login / Signup

Medication Regimen Complexity and Hospital Readmission in Older Adults With Chronic Kidney Disease.

Wubshet Hailu TesfayeGregory M PetersonRonald L CastelinoCharlotte McKercherMatthew D JoseBarbara C WimmerSyed Tabish R Zaidi
Published in: The Annals of pharmacotherapy (2018)
Overall, 50 (24%) patients, predominantly men (72%), were readmitted within 30 days of follow-up. MRCI was not significantly associated with 30-day readmission (odds ratio [OR] = 1.27; 95% CI = 0.94-1.73). The median (interquartile range) time to readmission within 12 months was 145 (31-365) days. On a multivariate analysis, a 10-unit increase in MRCI was associated with a shorter time to readmission within 12 months (subdistribution HR = 1.18; 95% CI = 1.01-1.36). Conclusion and Relevance: Medication regimen complexity was not significantly associated with 30-day readmission; however, it was associated with a significantly shorter time to 12-month readmission in older CKD patients. This finding highlights the importance of medication regimen complexity as a potential target for medical interventions to reduce readmission risks.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • healthcare
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • adverse drug
  • prognostic factors
  • human health
  • patient reported outcomes
  • african american